Analysis of desmethylmethsuximide using high-performance liquid chromatography

Area of Science:

• Analytical Chemistry
• Pharmacology
• Clinical Chemistry

Background:

• Desmethylmethsuximide is a key metabolite of methsuximide, an antiepileptic drug.
• Accurate quantification of desmethylmethsuximide is crucial for therapeutic drug monitoring (TDM).
• Existing analytical methods may lack the sensitivity or efficiency required for routine clinical use.

Purpose of the Study:

• To develop and validate a sensitive and accurate high-performance liquid chromatography (HPLC) method for the quantification of desmethylmethsuximide in human plasma.
• To establish a reliable method for therapeutic drug monitoring of desmethylmethsuximide.

Main Methods:

• Plasma samples (200 µL) were buffered to pH 4.5 and extracted using dichloroethane with an internal standard.
• The organic extract was evaporated, reconstituted in mobile phase, and injected onto a Hypersil 5 MOS column.
• Separation was achieved using an acetonitrile/acetate buffer (36:64 v/v) mobile phase with detection at approximately 8 minutes.

Main Results:

• The developed HPLC method demonstrated accurate quantification of desmethylmethsuximide down to 1.0 mg/L in plasma.
• The method showed good separation and sensitivity for the target analyte.
• The assay is robust and suitable for routine clinical laboratory analysis.

Conclusions:

• A validated HPLC method provides accurate and sensitive measurement of desmethylmethsuximide in plasma.
• This method is well-suited for therapeutic drug monitoring, aiding in optimizing patient treatment with methsuximide.
• The established analytical procedure supports clinical decision-making in epilepsy management.